Dr. Daniel Nomura Was Appointed Editor-in-Chief of Molecular Cancer Therapeutics
The American Association for Cancer Research (AACR) has appointed Daniel K. Nomura, PhD, as the editor-in-chief of Molecular Cancer Therapeutics, one of its 10 prestigious journals.
Dan Nomura is a Professor of Chemical Biology and Molecular Therapeutics at UC Berkeley, where he also serves as Co-Director of the Molecular Therapeutics Initiative and Director of the Novartis-Berkeley Translational Chemical Biology Institute.
He is the Co-Founder of Frontier Medicines, Vicinitas Therapeutics, and Zenith, and holds positions on several scientific advisory boards. Nomura is an Investment Advisory Partner at a16z Bio+Health and an iPartner with The Column Group.
“Dr. Nomura is an innovative scientist who is extremely well versed in emerging cancer therapeutics, including small molecules, biologics, vaccines, and cell therapies.
His expertise makes him an excellent choice for editor-in-chief of Molecular Cancer Therapeutics. The AACR is thrilled to work with him in this important role.” – Margaret Foti, PhD, MD (hc), Chief Executive Officer of the AACR.
He earned his B.A. in Molecular and Cell Biology in 2003 and Ph.D. in Molecular Toxicology in 2008 from UC Berkeley. His honors include the National Cancer Institute Outstanding Investigator Award and the Searle Scholar award.
“I am extremely honored to serve as the next editor-in-chief of Molecular Cancer Therapeutics. In this position, I look forward to establishing this publication as a leading high-impact journal for cutting-edge and emerging cancer therapies across all current and novel therapeutic modalities.” – Daniel Nomura
About The Journal
Molecular Cancer Therapeutics publishes research focused on the discovery and preclinical development of oncology therapies. The journal covers a wide range of selective drugs, including small molecule inhibitors, antibody-drug conjugates, bispecific antibodies, cell therapies, gene therapies, vaccines, and other experimental oncology treatments.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023